87.11
Overview
News
Price History
Option Chain
Financials
Why CLX Down?
Discussions
Forecast
Stock Split
Dividend History
Clorox Co stock is traded at $87.11, with a volume of 13.25M.
It is down -9.67% in the last 24 hours and down -16.43% over the past month.
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
See More
Previous Close:
$96.44
Open:
$90.99
24h Volume:
13.25M
Relative Volume:
5.33
Market Cap:
$10.53B
Revenue:
$6.76B
Net Income/Loss:
$770.00M
P/E Ratio:
14.23
EPS:
6.1203
Net Cash Flow:
$778.00M
1W Performance:
-11.72%
1M Performance:
-16.43%
6M Performance:
-22.54%
1Y Performance:
-37.12%
Clorox Co Stock (CLX) Company Profile
Name
Clorox Co
Sector
Industry
Phone
(510) 271-7000
Address
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX vs PG, UL, CL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CLX
Clorox Co
|
87.11 | 10.53B | 6.76B | 770.00M | 778.00M | 6.1203 |
|
PG
Procter Gamble Co
|
147.26 | 342.91B | 86.72B | 16.69B | 15.03B | 6.8375 |
|
UL
Unilever Plc Adr
|
59.76 | 130.51B | 56.67B | 6.96B | 7.39B | 3.1265 |
|
CL
Colgate Palmolive Co
|
87.26 | 70.01B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
KVUE
Kenvue Inc
|
17.43 | 33.46B | 15.12B | 1.47B | 1.72B | 0.764 |
|
KMB
Kimberly Clark Corp
|
97.67 | 32.42B | 16.56B | 1.75B | 1.84B | 6.36 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-11-26 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Oct-01-25 | Reiterated | Barclays | Underweight |
| Jan-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-06-24 | Upgrade | TD Cowen | Sell → Hold |
| Oct-01-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-23-24 | Initiated | TD Cowen | Sell |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Apr-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Mar-26-24 | Upgrade | Jefferies | Underperform → Hold |
| Mar-01-24 | Resumed | Goldman | Sell |
| Feb-05-24 | Downgrade | DA Davidson | Buy → Neutral |
| Dec-15-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-22-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-13-23 | Initiated | Jefferies | Underperform |
| Nov-06-23 | Upgrade | UBS | Sell → Neutral |
| Nov-02-23 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Oct-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-02-23 | Upgrade | DA Davidson | Neutral → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Hold |
| Aug-03-23 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Feb-17-23 | Initiated | Citigroup | Neutral |
| Oct-18-22 | Initiated | Evercore ISI | Underperform |
| Oct-17-22 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-14-22 | Resumed | BofA Securities | Underperform |
| Jul-13-22 | Initiated | Raymond James | Outperform |
| Feb-04-22 | Downgrade | Atlantic Equities | Neutral → Underweight |
| Feb-04-22 | Reiterated | Deutsche Bank | Hold |
| Feb-04-22 | Reiterated | JP Morgan | Underweight |
| Feb-04-22 | Reiterated | Morgan Stanley | Underweight |
| Feb-04-22 | Reiterated | UBS | Sell |
| Feb-04-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | Bernstein | Mkt Perform → Underperform |
| Jan-26-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-02-21 | Reiterated | DA Davidson | Neutral |
| Nov-02-21 | Reiterated | Deutsche Bank | Hold |
| Nov-02-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-02-21 | Reiterated | Wells Fargo | Underweight |
| Sep-03-21 | Downgrade | Argus | Buy → Hold |
| Aug-04-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Aug-04-21 | Reiterated | Citigroup | Buy |
| Aug-04-21 | Reiterated | Credit Suisse | Neutral |
| Aug-04-21 | Reiterated | Deutsche Bank | Hold |
| Aug-04-21 | Reiterated | Morgan Stanley | Underweight |
| Aug-04-21 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-04-21 | Reiterated | UBS | Sell |
| Aug-04-21 | Reiterated | Wells Fargo | Underweight |
| Jun-24-21 | Initiated | UBS | Sell |
| May-03-21 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-18-21 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-19-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Dec-14-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Oct-16-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-20 | Initiated | DA Davidson | Buy |
| Mar-19-20 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-16-20 | Upgrade | JP Morgan | Underweight → Overweight |
| Mar-09-20 | Upgrade | Argus | Hold → Buy |
| Oct-03-19 | Reiterated | BofA/Merrill | Neutral |
| Sep-23-19 | Downgrade | Barclays | Equal Weight → Underweight |
| May-20-19 | Downgrade | Argus | Buy → Hold |
| May-02-19 | Reiterated | BofA/Merrill | Neutral |
| May-02-19 | Upgrade | Deutsche Bank | Sell → Hold |
| Apr-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-07-19 | Initiated | Credit Suisse | Outperform |
| Dec-06-18 | Reiterated | BofA/Merrill | Neutral |
| Sep-25-18 | Upgrade | Argus | Hold → Buy |
| Jul-18-18 | Downgrade | Goldman | Neutral → Sell |
| Apr-19-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-08-18 | Downgrade | Argus | Buy → Hold |
| Jan-04-18 | Upgrade | BofA/Merrill | Underperform → Neutral |
View All
Clorox Co Stock (CLX) Latest News
The Clorox Company Q3 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
Is Clorox Co (CLX) a Bargain After 9.7% Drop? GF Value Says Unde - GuruFocus
Clorox Co. stock underperforms Friday when compared to competitors - MSN
Clorox’s Purell Deal Expands Health Focus As Earnings Outlook Softens - simplywall.st
Clorox (NYSE:CLX) Given New $97.00 Price Target at Citigroup - MarketBeat
These Analysts Lower Their Forecasts On Clorox Following Q3 EarningsClorox (NYSE:CLX) - Benzinga
Clorox (NYSE:CLX) Price Target Lowered to $95.00 at JPMorgan Chase & Co. - MarketBeat
Clorox (CLX) Faces Challenges with Mixed Q3 Results and Downgraded Outlook - GuruFocus
Why Clorox (CLX) Shares Are Getting Obliterated Today - The Globe and Mail
TD Cowen cuts Clorox stock price target on guidance cut, ERP issues - Investing.com Canada
Clorox (NYSE:CLX) Shares Gap Down Following Analyst Downgrade - MarketBeat
Morgan Stanley Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price - MarketBeat
Clorox stock hits 52-week low at $91.00 amid challenging year - Investing.com
Vanguard Group Inc. Lowers Stock Position in The Clorox Company $CLX - MarketBeat
SanDisk, Western Digital, Clorox And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
UBS cuts Clorox stock price target on weaker guidance outlook - Investing.com
Morgan Stanley cuts Clorox stock price target on sales struggles By Investing.com - Investing.com India
Evercore ISI cuts Clorox stock price target on margin pressures By Investing.com - Investing.com Canada
Goldman Sachs cuts Clorox stock price target on guidance reduction - Investing.com
Clorox Co (CLX) Q3 2026 Earnings Call Highlights: Navigating Challenges with Strategic Innovations By GuruFocus - Investing.com Canada
Clorox Co (CLX) Q3 2026 Earnings Call Highlights: Navigating Cha - GuruFocus
CLX SWOT Analysis: Key Insights from Q2 2026 10-Q Filing - GuruFocus
Clorox Sees Margin Hit from Middle East Conflict, Consumer Pressure - CookOut News
Clorox (CLX) Q3 FY2026: EPS $1.54 vs $1.51 Est (Beat), Revenue $ - GuruFocus
Clorox (CLX) Revises Gross Margin Projections Amid Various Headw - GuruFocus
CLX Sees Decline in Gross Margin Amid Rising Costs - GuruFocus
Earnings call transcript: Clorox Q3 2026 beats EPS estimates amid mixed results - Investing.com Canada
Clorox (NYSE:CLX) Releases FY 2026 Earnings Guidance - MarketBeat
Clorox slides as FY2026 profit outlook is cut and margin expectations worsen - Quiver Quantitative
Clorox Co. stock outperforms competitors on strong trading day - MarketWatch
Clorox shares fall 6% as weak guidance overshadows Q3 earnings beat - Investing.com Canada
Consumer Products Giant Clorox Shares Are Hitting New 52-Week Lows Thursday: Here's Why - Benzinga
Clorox (NYSE:CLX) Posts Q1 CY2026 Sales In Line With Estimates But Stock Drops - Yahoo Finance
Q3 2026 Clorox Co Earnings Call Transcript - GuruFocus
Clorox (NYSE: CLX) posts Q3 2026 results and closes $2.25B GOJO deal - Stock Titan
CLOROX|DE ($CLX) Releases Q3 2026 Earnings - Quiver Quantitative
Clorox: Fiscal Q3 Earnings Snapshot - marketscreener.com
Chair and CEO Linda Rendle on Q3 FY26 performance and outlook - The Clorox Company
Clorox (NYSE: CLX) cuts 2026 EPS outlook as GOJO deal closes - Stock Titan
Clorox Reports Q3 Fiscal Year 2026 Results, Updates Outlook - Stock Titan
MSN Money - MSN
Clorox (CLX) Expected Earnings and Market Developments - GuruFocus
Clorox set to report earnings amid cost pressures, guidance concerns - Investing.com UK
Clorox set to report earnings amid cost pressures, guidance concerns By Investing.com - Investing.com Australia
Clorox Co. Stock (US1890541097): Declares Quarterly Dividend of 30 Cents Per Share - AD HOC NEWS
Clorox (CLX) Set to Report Q3 Earnings with Strong Expectations - GuruFocus
Vanguard Capital Management stakes 7.35% in Clorox (NYSE: CLX) - Stock Titan
Clorox Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Clorox Co. Stock Plummets to New 52-Week Low at $95.73 - Markets Mojo
Clorox (CLX) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
The Clorox Co. Stock Plummets to New 52-Week Low at $96.38 - Markets Mojo
Clorox Co Stock (CLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):